Structural component of zinc-finger transcription factors (including AR, VDR, p53) and catalytic cofactor for carbonic anhydrase, alkaline phosphatase, DNA/RNA polymerases, and CuZn-SOD. Required for 5α-reductase and testicular testosterone synthesis. Intestinal uptake via ZIP4; efflux to portal blood via ZnT1. Competes with copper for DMT1 at high doses.
Dietary Reference Intake
FDA Daily Value 11 mg (21 CFR 101.9). NIH ODS UL 40 mg/d (copper antagonism above).
Half-Life & Elimination Curve (PO: 6h)
Plasma (PO)t½ Decay (6h)
0×t½0h100%(0.314 mg/L)
1×t½6h50%(0.157 mg/L)
2×t½12h25%(78.5 µg/L)
3×t½18h12.5%(39.2 µg/L)
4×t½24h6.3%(19.6 µg/L)
5×t½30h3.1%(9.81 µg/L)
Elimination t½6h (PO)
Rate Constant (ke)0.116 h⁻¹
Time to Peak (Tmax)2.44h
Est. Peak (Cmax)0.314 mg/L
Clearance (CL)1.62 L/h
97% Washout (5×t½)30h
Dosing Guidelines
Oral (PO): Typical 23.3 mg (Range: 15–40 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 25% · Volume of Distribution (Vd): 14 L · Absorption (ka): 1 h⁻¹ (t½ka ≈ 42m) [PMID 18271278]
Copper (caution): Zn induces metallothionein in enterocytes, which preferentially binds Cu and blocks its absorption. Chronic high-dose Zn → Cu deficiency.
Iron (caution): Competitive DMT1 absorption. Separate by 2 h.
Quercetin (synergistic): Ionophore mechanism — intracellular Zn²⁺ rises with co-administration.
Magnesium (caution): Competes for DMT1 transporter at high doses. Take 2 h apart.
Zinc Picolinate (synergistic): Same elemental mineral — picolinate is a commonly chosen well-tolerated form.